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Rat brain microtubule-associated protein MAPlB has been tested as a substrate for SerlThr protein phosphatases (PP). The dephosphorylatlon 
reactions were followed by specific antibodies recognizing phosphorylated and phosphorylatable epitopes. One set of phosphorylatlon sites on 
MAPlB are referred to as mode I sites. and their phosphorylation is presumably catalyzed by proline-directed protein kmases. These mode I sites 
are efficiently dephosphorylated by PP2B and 2A but not by PPl. Another set of phosphorylatlon sites on MAPI B are named mode II sites, and 
their phosphorylation is possibly due to casein kinase II. These mode II sites are dephosphorylated by PP2A and PPl, the PP2B being meffectlve 
The selectivity of phosphatases for different sites within the same protem indicates the complexity of the dephosphorylation reactions regulating 
the functionality of MAPIB in neurons. 
Phosphorylation/dephosphorylatlon: Microtubule-associated protein; Protem phosphatase 1 and 2A. Calcineunn: Proline direct protem kinase 
(PDPK): Casein kmase II (CKII) 
1. INTRODUCTION 
The growth and maintenance of neuronal processes 
depend on microtubules which are mainly composed of 
tubulin and a group of microtubule-associated proteins 
(MAPS). It has been suggested that MAPS play a role 
in the regulation of microtubule assembly and stabiliza- 
tion [l]. In particular a microtubule-associated protein 
referred to as MAPlB, MAP5 or MAPlX is mainly 
present in neurons at early developmental stages [2,3], 
and its phosphorylation has been correlated with 
neurite extension [4&9]. Interestingly, MAP1 B hyper- 
phosphorylation has been found associated with dys- 
trophic neurites and neurofibrillary tangles within 
brains of Alzheimer’s disease patients [lo]. 
Further analyses on the phosphorylation of MAPlB 
have indicated the existence of at least two major modes 
of MAP1 B phosphorylation [l 11. These are the result of 
the modification of MAP1 B by distinct protein kinases 
and can be recognized by the use of different antibodies 
to phosphorylation-sensitive epitopes [17]. Mode I- 
phosphorylated MAPlB is abundant in newborn and 
early postnatal rat brain, whereas it is hardly detectable 
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in most adult rat brain regions, with the exception of the 
olfactory bulb. where axonal growth persists into adult- 
hood. In contrast, mode II-phosphorylated MAPlB is 
also present in adult rat brain. Preliminary results indi- 
cate that a proline-directed protein kinase (PDPK) may 
be involved in mode I phosphorylation while mode II 
of MAP1 B phosphorylation may be catalyzed by casein 
kinase II [11,17]. 
Thus, phosphorylation of MAPlB. especially on 
mode I sites, should be considered as a dynamic process. 
The mode I phosphorylation seems to be important for 
axonal growth, whereas the corresponding dephos- 
phorylation may accompany axonal maturation, as sug- 
gested by Riederer et al. [12]. Consequently, it is impor- 
tant to know not only the protein kinases involved in 
these modifications but also the protein phosphatases 
that could dephosphorylate MAPIB. Different 
phosphatases have been described in mammalian tis- 
sues, including brain, and have been classified into 
phosphatases (PP) 1, 2A, 2B and 2C [13-l 51. 
In this work we have analyzed the action of PPl, 
PP2A and PP2B on phosphorylated MAPlB 
(pMAP1B) at mode I and mode II sites that are recog- 
nized by specific antibodies. 
2. MATERIALS AND METHODS 
2.1. Antibodies 
AntIbodies to MAPlB used in this study include mouse monoclonal 
(IgM) antibody 125 (obtained in our laboratory), mouse monoclonal 
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(IgM) antibody 150 (a generous gift from Dr. C. Albert0 and Dr F 
Moya. Umverstty of Ahcante, Spam). rabbit polyclonal antibody 842. 
raised against the synthetic peptide ASTYSYETSD (correspondmg to 
residues 3.050-2.059 of the MAP1 B sequence accordmg to Noble et 
al. [16]) and rabbit polyclonal antibody 531, raised against the syn- 
thetic peptide SPAKSPSLSPSPPSP (correspondmg to residues 1.247- 
1,261 of the MAPIB sequence according to Noble et al. [16]). These 
antibodies have previously been characterized by Ulloa et al [ 1 I 171 
2.2. PrOtCm prepuratlon 
Microtubule protem from 5-day-old rat bram cytosol was prepared 
accordmg to the procedure of Karr et al [18] From this preparation, 
MAPS with no associated kinase nor phosphatase activtttes were ob- 
tained as described by Diaz-Nido et al. [6] 
The catalytic subunits of protein phosphatase 1 (PPIL) and protein 
phosphatase ?A (PP2A,) were isolated from rabbit skeletal muscle 
[19,20]. Both preparations were homogeneous as detected by sodmm 
dodecyl sulfate (SDS) gel electrophoresis. The activity of PPI, and 
PP2A, was measured using [“PI-phospholabeled phosphorylase ‘a’ as 
substrate [?l]. Calcineurm (PPZB) was purified to apparent homoge- 
neity (29 Uimg) from bovine bram [22], PP2B activity was determined 
using [“PI-phospholabeled Inhibitor-1 [23] accordmg to the method of 
Yang et al [24]. One unit of phosphatase dephosphorylates 1 nmol of 
substrate m 1 min under the assay conditions. 
Calmodulin was prepared from porcine bram [25]. 
Protein was determined according to Read and Northcote [26] using 
bovine serum albumm as a standard. 
Aliquots (500 ~1) of a bram MAP preparation at a protein concen- 
tration of 1.2 mg/ml m buffer 20 mM PIPES buffer, pH 6 9. 0.5 mM 
EGTA were preincubated at 30°C for 1 mm. Dephosphorylatton 
reactions were started by the addition of purified PPlc or PP2Ac at 
final concentrations of 10 U/ml in 50 mM Tris-HCl buffer, pH 7.5.0.1 
mM EDTA. 10 mM DTT, or purified PP2B at a final concentration 
of 3 U/ml in 40 mM Tris-HCl buffer, pH 7.0. 0.4 mM DTT. 0 2 mM 
CaCl?. 1 mM MnCl, containing 12 PM calmoduhn at 30°C. The 
reactions were stopped after 3. 10 and 45 mm incubation by the 
addition of SDS sample buffer, mtxmg. and freezing in hqutd rntrogen. 
All reactions contained 5 mM benzamidine, 1 mM o-phenanthrohne 
and 0.2 mM PMSF as protease mhtbitora. 
Proteins were separated on SDS-polyacrylamtde gels (SDS-PAGE) 
according to the procedure of Laemmh [27] using 410% gradient 
polyacrylamide gels, with the modifications previously described [17] 
Protein electroblotting was performed as described by Towbin et al. 
[28] with a modified transfer buffer (20% (v/v) methanol. 25 mM 
Trts-HCI. 200 mM glycme. pH 7.0 and 0.1% SDS). Transferred pro- 
tems were stained wtth 0.3% Ponceau-S III 3% trichloroacettc acid for 
15 min. After blockmg the membranes with 2% bovine serum albumin 
m 20 mM sodium phosphate. pH 7 4. 140 mM NaCl containing 0.1% 
Tween 20 during 1 h at room temperature. the blots were incubated 
with primary antibodies overmght at 4OC. Detection of bound antt- 
bodies was performed by mcubation with a second peroxldase-conju- 
gated antiserum (Daho-Dtuwark) at the manufacturer’s recom- 
mended dilution. Detection was performed using the ECL detection 
system (Amersham UK). After washing. with phosphate-bulfered sa- 
line containing 0.1% Tween 20, the labeled proteins were characterized 
by autoradiography of the dried blots exposed to Kodak X Omat lilms 
and quantified by densitometrtc scanning using a Densitometer model 
2OOA from Molecular Dynamics. 
3. RESULTS 
3.1. Depllospllor~lutioil of pllosphorl~luted MAPIB 
(pMA Pl B i on mode I sites 
The mode I of MAPlB phosphorylation can be iden- 
tified by the use of two antibodies [17], one recognizing 
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Fig. 1. Analysis of pMAPlB dephosphorylation at 150 and 531 epitopes. Left. Autoradiograms of immunoblots with antibodies 150 (upper panels) 
and 531 (lower panels) of a MAPS preparation treated with PPl, (left), PP?A, (center) or PP2B (right) for 1. 3. 10. or 45 mm Arrows (4) indicate 
the MAPlB position and the arrowheads mark the ~260 proteolytic fragment of MAPlB Right. Kinetics of pMAPlB dephosphorylation at 150 
and 531 epitopes. Quantification of the immunoreactivtty of MAPlB toward antibodies 150 and 531 after dephosphorylation with PPl,, PPZA, 
or PPZB. Bars indicate the S D. values of the mean. from different experiments. 
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Fig. 2. Analysis of MAPlB dephosphorylation at 125 and 842 epitopes Left. Autoradiograms of tmmunoblots with antibodies 125 (upper panels) 
and 842 (lower panels) of a MAPS preparation treated wtth PPl, (left). PP?A, (center) or PPZB (right) for 1, 3, 10, or 45 min. Arrows (-1) indicate 
the MAPlB position and the arrowheads mark the ~260 proteolytic fragment of MAPlB. Right. Kinetics of pMAPlB dephosphorylatton at 125 
and 842 epltopes. Quanttficatton of the tmmunoreacttvity of MAPIB toward antlbodtes 125 and 842 after dephosphorylation wrth PPl,. PP2A, 
or PP2B. Bars Indicate the S.D. values of the mean, from different expertments 
a phosphorylated epitope (antibody 150) and another 
reacting with a phosphorylatable epitope when it is 
unphosphorylated (antibody 531). We have used these 
antibodies to test for the dephosphorylation of 
pMAPlB with purified phosphatases PPl,, PP2A, and 
PP2B. Phosphatase treatment was performed for differ- 
ent times until 45 min to measure the rate of 
dephosphorylation and the final extent of it (Fig. 1). 
Incubation of pMAPlB with PP2A2 leads to an increase 
in the reaction of MAPlB with antibody 531 and a 
decrease in the reaction of MAPlB with antibody 150. 
The effect of PP2B is even more marked and an increase 
in the overall electrophoretic mobility of phosphatase- 
treated MAPlB was also found. No effect is observed 
with PPl,. It is apparent that dephosphorylation of 
pMAP1 B at the 150 epitope is almost complete in 3 min 
with PP2B. No variations in the immunoreactivity of 
MAPlB for these antibodies are observed when MAPS 
are incubated in the absence of purified phosphatases 
(data not shown). 
3.2. Dephosphor~~lation of pMAPlB on mode II sites 
To test for the dephosphorylation of MAPlB on 
mode II sites, a similar approach has been followed. In 
this case, antibody 125, which recognizes a 
phosphorylated epitope that can be phosphorylated in 
vitro with casein kinase II [l l] and antibody 842, which 
binds to an unmodified epitope which is also 
phosphorylatable by casein kinase II [17], were em- 
ployed. These two epitopes are located apart on the 
MAPlB molecule, as detected by limited proteolysis 
with calpain in which two main fragments are gener- 
ated. The larger phosphorylated 260 kDa proteolytic 
fragment (p260), which contains the N-terminal domain 
and the epitope for antibody 125, is also usually present 
in MAPlB preparation (Fig. 2). The smaller fragment 
contains the epitope for antibody 842 and the C-termi- 
nal end [17]. 
Fig. 2 shows that PP2A, and PPl, can dephospho- 
rylate pMAPlB at these sites. whereas PP2B is ineffec- 
tive. Again, no variations in the immunoreactivity of 
MAPlB for antibodies 125 and 842 were observed in 
the absence of phosphatases (data not shown). 
MAPlB could be resolved, by gel electrophoresis 
under certain conditions, into two different isoforms 
with different electrophoretic mobilities [17]. The 
phosphoisoform with a slower mobility is modified by 
the mode I of phosphorylation whereas the other 
(faster) one is only phosphorylated by the mode II. In 
Fig. 2 (upper panel PP-2B) it is shown that PP-2B treat- 
ment results in the disappearance of phosphoMAPlB 
isoform with the slower electrophoretic mobility but not 
of the faster migrating form. This result is consistent 
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with the observed dephosphorylation of mode I- 
phosphorylated MAPlB by PP2B. 
4. DISCUSSION 
Distinct phosphorylation sites on the MAPlB mole- 
cule are differentially susceptible to in vitro 
dephosphorylation with purified protein phosphatases. 
Thus, the sites constituting the epitopes for antibodies 
150 and 531 (mode I sites), which are presumably 
phosphorylated by proline-directed protein kinases [17]. 
are readily dephosphorylated by PP2A and PP2B. and 
PPl having no effect. In contrast, the sites constituting 
the epitopes for antibodies 125 and 842. which are pre- 
sumably phosphorylated by casein kinase II [l 1,171 are 
dephosphorylated by both PP2A and PPl, PP2B being 
ineffective. It should be mentioned that strict quantita- 
tive comparisons of specific dephosphorylation rates 
cannot be made. This particularly holds for PP2B. 
which was assayed with a substrate different from that 
used for PPl and PP2A. Nevertheless, the ability of 
PP2A to dephosphorylate both mode I and mode II 
sites, that of PP2B to dephosphorylate mode I sites, as 
well as that of PPl to dephosphorylate mode II sites, 
can be clearly established. 
These results are compatible with previous data on 
the specificity of protein phosphatases toward synthetic 
peptide substrates. Thus, the catalytic subunit of PP2A 
is more effective than PPl in the dephosphorylation of 
several synthetic peptides phosphorylated by p34 cdc2, 
which is a proline-directed protein kinase [29]. Interest- 
ingly, the oligomeric structure of the PP2A 
phosphatases is quite important for the efficient 
dephosphorylation of these substrates, suggesting a reg- 
ulatory role for associated subunits. Similar results have 
been obtained upon studying the PPZA-catalyzed 
dephosphorylation of microtubule-associated tau pro- 
tein at the tau-1 epitope [30], which is a site 
phosphorylated by proline-directed protein kinases in- 
cluding cdc2 kinase [31,32]. In addition, histone HI 
phosphorylated by the cdc3 kinase was also best 
dephosphorylated by PP2A [33]. Furthermore, PP2A 
has been shown to dephosphorylate synthetic peptides 
phosphorylated by casein kinase II [34]. However, in 
this case, the primary structure of the phosphorylation 
sites is important in determining the dephosphorylation 
rates. This would explain why some sites 
phosphorylated by casein kinase II are only slowly 
dephosphorylated by PP2A [35,36]. 
Further research is required to understand the rela- 
tive roles played by kinase and phosphatase activities in 
controlling the state of phosphorylation of MAPlB in 
different neuronal compartments during development. 
Thus, MAPlB phosphorylated at the 150 epitope is 
confined to the distal, growing portions of developing 
axons [9] whereas MAPlB phosphorylated at the 125 
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epitope shows a widespread distribution including axon 
and dendrites of developing and mature neurons (Ulloa 
et al., submitted). 
It is not known whether an increase in phosphatase 
activity and/or a decrease in kinase activity is/are re- 
sponsible for the net dephosphorylation on MAPlB at 
the 150 epitope which is observed during axonal matu- 
ration [9,17]. This dephosphorylation seems to affect 
the mode I-phosphorylated sites on the MAPlB mole- 
cule, as it is correlated with the disappearance of the 
slower-migrating MAP1 B isoform on SDS-PAGE 
[ 12.171. A defect in protein dephosphorylation by PP2A 
has also been suggested to play a role in the hyper- 
phosphorylation of neuronal proteins phosphorylated 
by proline-directed protein kinases in Alzheimer’s dis- 
ease [30]. 
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